Your mind is part of your biology.

Problem

Cancer treatment has never been more effective. But effectiveness is only part of the picture.

Between appointments, patients carry their diagnosis alone. Fear, uncertainty, and the psychological weight of treatment don’t pause when the clinical team goes home. And the relationship between a patient’s psychological state and their physical resilience — while increasingly recognized in research — remains almost entirely unaddressed by existing care systems.

Most oncology support tools are passive. They provide information, reminders, and check-ins. Few are designed to actively support the patient’s inner experience — their sense of agency, their emotional resilience, their relationship with their own body — in a continuous, personalized, and genuinely adaptive way.

The hours between appointments are where patients need support most. That is exactly where the current system leaves them alone.

Overview

LumeVV™ is an adaptive immersive oncology support platform that works alongside clinical treatment — not instead of it. It delivers continuous, personalized support designed to engage the patient’s own psychological resilience, sense of agency, and capacity for healing.

The platform evolves with the patient throughout their treatment journey — responding to where they are, what they need, and how they’re doing — so support is always personal, always present, and never generic.

Solution — What It Delivers

• Continuous personalized support available at any hour — during treatment, between appointments, and through the hardest moments of the journey.
• An immersive support environment that engages the patient’s psychological resilience and sense of agency throughout the full arc of care.
• Personalized guidance tailored to the individual patient’s journey, beliefs, and needs.
• A platform that learns and evolves with the patient — never static, never generic, always personal.
• Support that works alongside the clinical team — giving oncologists a continuous care presence that extends meaningfully beyond the appointment.

For patients: a presence that understands. For clinicians: a partner that extends the reach of care.

Market

The clinical case for supporting the patient’s mind during cancer treatment is established. The platform to do it continuously, personally, and at scale has not existed. Until now.

Why It’s Different

• Most oncology support is episodic. LumeVV™ is continuous.
• Most support tools are passive. LumeVV™ actively engages the patient’s own resilience and sense of agency.
• Most platforms provide information. LumeVV™ provides presence.
• Most digital health tools feel generic. LumeVV™ evolves with the individual patient throughout their unique journey.
• Most care ends at the appointment. LumeVV™ is there for the 167 hours a week when the clinical team is not.

Science Foundation

• Psycho-oncology and mind-body medicine
• Psychological resilience and cancer outcomes research
• Immersive therapeutic environment research
• Adaptive personalized support systems
• Patient experience and quality-of-life research in oncology
• Existential wellbeing and meaning-making in cancer care

Intellectual Property

Patent filed.